O'Shaughnessy Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
73,652
-12,624
| -15% | -$212K | 0.01% | 968 |
|
|
2025
Q1 | $1.33M | Sell |
86,276
-26,241
| -23% | -$403K | 0.01% | 876 |
|
|
2024
Q4 | $2.48M | Sell |
112,517
-8,582
| -7% | -$189K | 0.02% | 597 |
|
|
2024
Q3 | $2.09M | Buy |
121,099
+91,433
| +308% | +$1.58M | 0.02% | 629 |
|
|
2024
Q2 | $482K | Buy |
29,666
+17,901
| +152% | +$291K | 0.01% | 1149 |
|
|
2024
Q1 | $166K | Buy |
+11,765
| New | +$166K | ﹤0.01% | 1532 |
|
|
2023
Q2 | – | Sell |
-10,700
| Closed | -$94.7K | – | 1575 |
|
|
2023
Q1 | $94.7K | Buy |
10,700
+487
| +5% | +$4.31K | ﹤0.01% | 1294 |
|
|
2022
Q4 | $93.1K | Buy |
+10,213
| New | +$93.1K | ﹤0.01% | 1208 |
|
|
2021
Q4 | – | Sell |
-1,286
| Closed | -$13K | – | 2363 |
|
|
2021
Q3 | $13K | Buy |
1,286
+145
| +13% | +$1.47K | ﹤0.01% | 2090 |
|
|
2021
Q2 | $11K | Sell |
1,141
-87,029
| -99% | -$839K | ﹤0.01% | 1982 |
|
|
2021
Q1 | $1.02M | Buy |
88,170
+87,634
| +16,350% | +$1.01M | 0.02% | 398 |
|
|
2020
Q4 | $5K | Hold |
536
| – | – | ﹤0.01% | 1688 |
|
|
2020
Q3 | $5K | Sell |
536
-91
| -15% | -$849 | ﹤0.01% | 1493 |
|
|
2020
Q2 | $8K | Buy |
+627
| New | +$8K | ﹤0.01% | 1305 |
|
|
2016
Q3 | – | Sell |
-3,199
| Closed | -$161K | – | 969 |
|
|
2016
Q2 | $161K | Sell |
3,199
-217
| -6% | -$10.9K | ﹤0.01% | 524 |
|
|
2016
Q1 | $186K | Sell |
3,416
-1,825
| -35% | -$99.4K | ﹤0.01% | 460 |
|
|
2015
Q4 | $344K | Sell |
5,241
-5,851
| -53% | -$384K | 0.01% | 400 |
|
|
2015
Q3 | $641K | Buy |
11,092
+5,632
| +103% | +$325K | 0.01% | 350 |
|
|
2015
Q2 | $323K | Sell |
5,460
-4,131
| -43% | -$244K | 0.01% | 434 |
|
|
2015
Q1 | $598K | Buy |
9,591
+6,869
| +252% | +$428K | 0.01% | 356 |
|
|
2014
Q4 | $157K | Buy |
2,722
+305
| +13% | +$17.6K | ﹤0.01% | 562 |
|
|
2014
Q3 | $130K | Buy |
2,417
+89
| +4% | +$4.79K | ﹤0.01% | 587 |
|
|
2014
Q2 | $122K | Buy |
+2,328
| New | +$122K | ﹤0.01% | 594 |
|